Sulis Pharmaceuticals Private Limited
About Sulis Pharmaceuticals Private Limited
Data last updated:
Sulis Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the retail trade segment of the trading and commerce sector. It was incorporated on 20 May 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2011PTC217686.
The company has an authorised share capital of ₹12 Lakh and a paid-up capital of ₹11.7 Lakh. It is led by directors Shashikant Krishnanand Mishra and Krishna Kumar Shashi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 23 Yashodham Complex Film Citi Road Goregaon (E), Mumbai, Maharashtra, India – 400063.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.17 Lakh. For the same year it recorded a net profit of ₹8,540 (net margin 0.4%) and EBITDA of ₹15,120 (EBITDA margin 0.8%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sulis Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address23 Yashodham Complex Film Citi Road Goregaon (E), Mumbai, Maharashtra, India – 400063
- IndustryTrading, Retailers, Retail Trading
To see the full contact details of Sulis Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sulis Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Sulis Pharmaceuticals Private Limited, buy the company report.
Financials of Sulis Pharmaceuticals Private Limited
FY 2025 filings availableSulis Pharmaceuticals Private Limited reported revenue of ₹19.17 Lakh for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15,120 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8,540 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sulis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sulis Pharmaceuticals Private Limited
Sulis Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shashikant Krishnanand Mishra Also directs: Ennoblehelps Private Limited | Additional Director | 10 Apr 2023 | 3 Years 6 Months | Current |
| Krishna Kumar Shashi | Additional Director | 10 Apr 2023 | 3 Years 6 Months | Current |
Auditor
Sulis Pharmaceuticals Private Limited is audited by Shailendra Vishnu for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Shailendra Vishnu | FY 2017 | 009832C |
Shareholding
The shareholding of Sulis Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sulis Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sulis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sulis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sulis Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sulis Pharmaceuticals Private Limited has 6 board changes on record since 2012: 2 appointments and 4 cessations. The latest: Himanshu ceased to be Director on 24 Mar 2024.
Frequently asked questions
Sulis Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in retailers, within the trading industry. It was incorporated on 20 May 2011 (15+ years old) and is registered under CIN U24239MH2011PTC217686.
Sulis Pharmaceuticals has 2 current directors:
- Shashikant Krishnanand Mishra - Additional Director
- Krishna Kumar Shashi - Additional Director
The latest financial statements of Sulis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Sulis Pharmaceuticals is U24239MH2011PTC217686. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sulis Pharmaceuticals was incorporated on 20 May 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
Himanshu ceased to be Director on 24 Mar 2024. Madhu Gupta ceased to be Director on 24 Mar 2024. Krishna Kumar Shashi was appointed as Additional Director on 10 Apr 2023. Sulis Pharmaceuticals has 6 board changes on record in total.
The registered office of Sulis Pharmaceuticals is at 23 Yashodham Complex Film Citi Road Goregaon E, Mumbai, Maharashtra, India – 400063.
Sulis Pharmaceuticals operates in the trading industry, in the retailers segment.
The compliance status of Sulis Pharmaceuticals is compliant as of 15 September 2026. The company is actively filing with the Registrar of Companies.
Sulis Pharmaceuticals can be reached at its registered office: 23 Yashodham Complex Film Citi Road Goregaon E, Mumbai, Maharashtra, India – 400063.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
